Silver Spike Investment Corp. (SSIC)
NASDAQ: SSIC · IEX Real-Time Price · USD
11.37
+0.12 (1.07%)
At close: May 24, 2024, 4:00 PM
11.25
-0.12 (-1.06%)
After-hours: May 24, 2024, 4:00 PM EDT

Company Description

Silver Spike Investment Corp., is a a business development company.

It is a specialty finance company, focuses on investing across the cannabis ecosystem through investments in the form of direct loans to, and equity ownership of, privately held cannabis companies.

It intends to partner with private equity firms, entrepreneurs, business owners, and management teams to provide credit and equity financing alternatives to support buyouts, recapitalizations, growth initiatives, refinancings, and acquisitions across cannabis companies, including cannabis-enabling technology companies, cannabis-related health and wellness companies, and hemp and CBD distribution companies.

The company was founded in 2021 and is based in New York, New York.

Silver Spike Investment Corp.
Silver Spike Investment logo
Country United States
Founded 2021
IPO Date Feb 4, 2022
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO Scott Charles Gordon

Contact Details

Address:
600 Madison Ave, Suite 1800
New York, New York 10022
United States
Phone (212) 905-4923
Website ssic.silverspikecap.com

Stock Details

Ticker Symbol SSIC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $14.00
CIK Code 0001843162
CUSIP Number 828174102
ISIN Number US8281741020

Key Executives

Name Position
Scott Charles Gordon Chairperson and Chief Executive Officer
Umesh Bhaskar Mahajan Chief Financial Officer
Roxanne Nicole Jenkins Chief Compliance Officer and Secretary

Latest SEC Filings

Date Type Title
May 13, 2024 425 Filing
May 10, 2024 425 Filing
May 10, 2024 425 Filing
May 10, 2024 8-K Current Report
May 9, 2024 10-Q Quarterly Report
May 1, 2024 8-K Current Report
Apr 26, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 26, 2024 DEF 14A Other definitive proxy statements
Apr 15, 2024 N-14 8C Filing
Mar 29, 2024 425 Filing